Rectal-wall dose dependence on postplan timing after permanent-seed prostate brachytherapy.
暂无分享,去创建一个
G. Pond | D. Taussky | I. Yeung | T. Williams | S. Pearson | M. Mclean | J. Crook
[1] W. Butler,et al. Rectal dosimetric analysis following prostate brachytherapy. , 1999, International journal of radiation oncology, biology, physics.
[2] F M Waterman,et al. Effect of post-implant edema on the rectal dose in prostate brachytherapy. , 1999, International journal of radiation oncology, biology, physics.
[3] The effect of constipation on rectal dosimetry following prostate brachytherapy. , 2000 .
[4] S Nag,et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. , 2000, International journal of radiation oncology, biology, physics.
[5] L. Potters,et al. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. , 2000, International journal of radiation oncology, biology, physics.
[6] R. Stock,et al. Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis. , 2001, International journal of radiation oncology, biology, physics.
[7] K. Wallner,et al. Dosimetric and radiographic correlates to prostate brachytherapy‐related rectal complications , 2001, International journal of cancer.
[8] K. Wallner,et al. American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy. , 2002, International journal of radiation oncology, biology, physics.
[9] A. Dicker,et al. Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0? , 2002, International journal of radiation oncology, biology, physics.
[10] C. Catton,et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. , 2002, International journal of radiation oncology, biology, physics.
[11] K. Wallner,et al. Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials. , 2003, Brachytherapy.
[12] Adam P Dicker,et al. Probability of late rectal morbidity in 125I prostate brachytherapy. , 2003, International journal of radiation oncology, biology, physics.
[13] M. Kattan,et al. Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] Patrick W McLaughlin,et al. The use of mutual information in registration of CT and MRI datasets post permanent implant. , 2004, Brachytherapy.
[15] Ivan Yeung,et al. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. , 2004, International journal of radiation oncology, biology, physics.
[16] L. Potters,et al. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk. , 2005, Brachytherapy.
[17] Caitlin Gillan,et al. Posttreatment Complications of Early‐Stage Prostate Cancer Patients: Brachytherapy Versus Three‐Dimensional Conformal Radiation Therapy , 2005, Cancer journal.